Clinicians commonly use urine drug tests to detect or validate self-reported drug use, particularly when beginning and maintaining opioid agonist therapy (for example buprenorphine or methadone). Until now, there has been no clinical consensus on urine drug testing frequency in Canada. National guidelines for opioid use disorder released: Canadian consensus on urine drug testing frequency Vancouver, … Continue reading Frequent urine testing lacks evidence